7+ Year Member
15+ Year Member
Jun 22, 2003
los angeles
Visit site
Bisphosphonates have been around for a while and there is a lot of recent publications in our journal associating bisphosphonates to ONJ. What needs to be done and what is currently in the works is a big multicenter retrospective study. The risk of developing ONJ is more closely linked to the newer generation bisphosphonates pamidronate and zolendronic acid. Fosamax is usually given in PO form and from the studies I have read through has only shown 1 or 2 case reports. It will be interesting to see what the bigger mulitcenter trial study shows because bisphosphonates are commonly used not only to treat osteoporosis but hypercalcemia from bone mets seen in breast CA, prostate CA...ect.

The other problem is that there is no overall defenitive tx for those who are diagnosed with ONJ from bisphosphonates. One tx has not been shown to help in all cases. Some have tried local debridement, HBO therapy, and more aggressive resection. For now the goal should be to have patients screened before undergoing tx with IV bisphosphonates just as patients are screened prior to undergoing radiation therapy.


10+ Year Member
5+ Year Member
Jul 14, 2004
On the hospital
I doen't think anyone would disagree with you above. Anecdotally we have seen numerous cases here, typically we treat them with a marginal resection with a plate or a very large local debridment with a bur. kinda like ORN without the HBO.

Fullosseousflap said:
Drugs linked to Death of jawbone
Ha, we give it a funeral? Looks like a quote from the paper about a guy named jawbone.


Wet-Gloved Dentist
10+ Year Member
7+ Year Member
Fullosseousflap said:
A Food and Drug Administration review posted last week on the agency's Web site suggests that osteonecrosis of the jaw (ONJ) is a risk of all bisphosphonates.

Check it out here.
Yes, that is how the media portrayed the headline...catchy huh?

Check out the FDA link and the FDA Powerpoint series of links at the link above for a more scientific approach.